Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2006-05-22 15:12:13 UTC |
---|
Update Date | 2021-09-14 15:18:11 UTC |
---|
HMDB ID | HMDB0002832 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Methylnoradrenaline |
---|
Description | Methylnoradrenaline, also known as a-methylnorepinephrine, belongs to the class of organic compounds known as phenylpropanes. These are organic compounds containing a phenylpropane moiety. Methylnoradrenaline has been detected, but not quantified in, a few different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), and domestic pigs (Sus scrofa domestica). This could make methylnoradrenaline a potential biomarker for the consumption of these foods. Based on a literature review a significant number of articles have been published on Methylnoradrenaline. |
---|
Structure | CC(N)C(O)C1=CC(O)=C(O)C=C1 InChI=1S/C9H13NO3/c1-5(10)9(13)6-2-3-7(11)8(12)4-6/h2-5,9,11-13H,10H2,1H3 |
---|
Synonyms | Value | Source |
---|
alpha-Methylnorepinephrine | Kegg | alpha-Methylnoradrenaline | Kegg | a-Methylnorepinephrine | Generator | Α-methylnorepinephrine | Generator | a-Methylnoradrenaline | Generator | Α-methylnoradrenaline | Generator | (+-)-3,4-Dihydroxynorephedrine | HMDB | (+/-)-3,4-dihydroxynorephedrine | HMDB | 3,4-Dihydrophenyl-1-amino-2-propanol-1 | HMDB | Dihydroxyphenylpropanolamine | HMDB | Dioxynorepinephrine | HMDB | DL-a-Methylnorepinephrine | HMDB | DL-alpha-Methylnorepinephrine | HMDB | Isoadrenaline | HMDB | L-a-Methylnorepinephrine | HMDB | L-alpha-Methylnorepinephrine | HMDB | Levonordefrin | HMDB, MeSH | Nordefrin | HMDB, MeSH | Nordefrin hydrochloride, (r*,r*)-(+,-)-isomer | MeSH, HMDB | Nordefrin, (r*,r*)-isomer | MeSH, HMDB | 3,4-Dihydroxynorephedrine | MeSH, HMDB | Cobefrine | MeSH, HMDB | Corbadrine | MeSH, HMDB | Nordefrin tartrate, (r*,r*), (r*,r*) isomer | MeSH, HMDB | 4-(2-amino-1-Hydroxypropyl)-1,2-benzenediol | MeSH, HMDB | 4-(2-amino-1-Hydroxypropyl)-1,2-benzenediol hydrochloride, (r*,r*)-(+,-)-isomer | MeSH, HMDB | 4-(2-amino-1-Hydroxypropyl)-1,2-benzenediol hydrochloride, (r*,s*)-(+-)-isomer | MeSH, HMDB | NeoCobefrin | MeSH, HMDB | alpha Methylnoradrenaline | MeSH, HMDB | 3,4 Dihydroxynorephedrine | MeSH, HMDB | 4-(2-amino-1-Hydroxypropyl)-1,2-benzenediol, (r*,r*)-isomer | MeSH, HMDB | 4-(2-amino-1-Hydroxypropyl)-1,2-benzenediol, (r*,s*)-isomer | MeSH, HMDB | Hydrochloride, nordefrin | MeSH, HMDB | neo-Cobefrin | MeSH, HMDB | Nordefrin hydrochloride | MeSH, HMDB | Nordefrin tartrate, (r*,s*), (r*,r*) isomer | MeSH, HMDB | Nordefrin, (r*,s*)-isomer | MeSH, HMDB | alpha Methylnorepinephrine | MeSH, HMDB | 4-(2-amino-1-Hydroxypropyl)-1,2-benzenediol tartrate, (r*,s*), (r*,r*)-isomer | MeSH, HMDB | Methylnorepinephrine | MeSH, HMDB | Norephrine | MeSH, HMDB | 4-(2-amino-1-Hydroxypropyl)-1,2-benzenediol tartrate, (r*,r*), (r*,r*)-isomer | MeSH, HMDB | neo Cobefrin | MeSH, HMDB | Nordefrin hydrochloride, (r*,s*)-(+,-)-isomer | MeSH, HMDB |
|
---|
Chemical Formula | C9H13NO3 |
---|
Average Molecular Weight | 183.2044 |
---|
Monoisotopic Molecular Weight | 183.089543287 |
---|
IUPAC Name | 4-(2-amino-1-hydroxypropyl)benzene-1,2-diol |
---|
Traditional Name | α methylnoradrenaline |
---|
CAS Registry Number | 6539-57-7 |
---|
SMILES | CC(N)C(O)C1=CC(O)=C(O)C=C1 |
---|
InChI Identifier | InChI=1S/C9H13NO3/c1-5(10)9(13)6-2-3-7(11)8(12)4-6/h2-5,9,11-13H,10H2,1H3 |
---|
InChI Key | GEFQWZLICWMTKF-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylpropanes. These are organic compounds containing a phenylpropane moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Phenylpropanes |
---|
Direct Parent | Phenylpropanes |
---|
Alternative Parents | |
---|
Substituents | - Phenylpropane
- Catechol
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Aralkylamine
- 1,2-aminoalcohol
- Secondary alcohol
- Organic nitrogen compound
- Aromatic alcohol
- Primary amine
- Hydrocarbon derivative
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Organic oxygen compound
- Amine
- Alcohol
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | -1.43 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.3 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 8.9897 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 5.44 minutes | 32390414 | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 282.9 seconds | 40023050 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 426.8 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 253.3 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 67.3 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 150.7 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 36.9 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 269.9 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 219.6 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 743.2 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 562.3 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 37.4 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 631.4 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 155.6 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 168.3 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 590.4 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 539.1 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 326.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Methylnoradrenaline,1TMS,isomer #1 | CC(N)C(O[Si](C)(C)C)C1=CC=C(O)C(O)=C1 | 1925.8 | Semi standard non polar | 33892256 | Methylnoradrenaline,1TMS,isomer #2 | CC(N)C(O)C1=CC=C(O)C(O[Si](C)(C)C)=C1 | 1857.3 | Semi standard non polar | 33892256 | Methylnoradrenaline,1TMS,isomer #3 | CC(N)C(O)C1=CC=C(O[Si](C)(C)C)C(O)=C1 | 1866.8 | Semi standard non polar | 33892256 | Methylnoradrenaline,1TMS,isomer #4 | CC(N[Si](C)(C)C)C(O)C1=CC=C(O)C(O)=C1 | 2032.1 | Semi standard non polar | 33892256 | Methylnoradrenaline,2TMS,isomer #1 | CC(N)C(O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O)=C1 | 1812.5 | Semi standard non polar | 33892256 | Methylnoradrenaline,2TMS,isomer #2 | CC(N)C(O[Si](C)(C)C)C1=CC=C(O)C(O[Si](C)(C)C)=C1 | 1803.0 | Semi standard non polar | 33892256 | Methylnoradrenaline,2TMS,isomer #3 | CC(N[Si](C)(C)C)C(O[Si](C)(C)C)C1=CC=C(O)C(O)=C1 | 1929.8 | Semi standard non polar | 33892256 | Methylnoradrenaline,2TMS,isomer #4 | CC(N)C(O)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1 | 1880.1 | Semi standard non polar | 33892256 | Methylnoradrenaline,2TMS,isomer #5 | CC(N[Si](C)(C)C)C(O)C1=CC=C(O)C(O[Si](C)(C)C)=C1 | 1893.9 | Semi standard non polar | 33892256 | Methylnoradrenaline,2TMS,isomer #6 | CC(N[Si](C)(C)C)C(O)C1=CC=C(O[Si](C)(C)C)C(O)=C1 | 1906.3 | Semi standard non polar | 33892256 | Methylnoradrenaline,2TMS,isomer #7 | CC(C(O)C1=CC=C(O)C(O)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2093.8 | Semi standard non polar | 33892256 | Methylnoradrenaline,3TMS,isomer #1 | CC(N)C(O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1 | 1846.2 | Semi standard non polar | 33892256 | Methylnoradrenaline,3TMS,isomer #2 | CC(N[Si](C)(C)C)C(O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O)=C1 | 1841.0 | Semi standard non polar | 33892256 | Methylnoradrenaline,3TMS,isomer #3 | CC(N[Si](C)(C)C)C(O[Si](C)(C)C)C1=CC=C(O)C(O[Si](C)(C)C)=C1 | 1841.3 | Semi standard non polar | 33892256 | Methylnoradrenaline,3TMS,isomer #4 | CC(C(O[Si](C)(C)C)C1=CC=C(O)C(O)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2089.3 | Semi standard non polar | 33892256 | Methylnoradrenaline,3TMS,isomer #5 | CC(N[Si](C)(C)C)C(O)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1 | 1910.2 | Semi standard non polar | 33892256 | Methylnoradrenaline,3TMS,isomer #6 | CC(C(O)C1=CC=C(O)C(O[Si](C)(C)C)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2053.3 | Semi standard non polar | 33892256 | Methylnoradrenaline,3TMS,isomer #7 | CC(C(O)C1=CC=C(O[Si](C)(C)C)C(O)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2079.2 | Semi standard non polar | 33892256 | Methylnoradrenaline,4TMS,isomer #1 | CC(N[Si](C)(C)C)C(O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1 | 1909.0 | Semi standard non polar | 33892256 | Methylnoradrenaline,4TMS,isomer #1 | CC(N[Si](C)(C)C)C(O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1 | 1963.7 | Standard non polar | 33892256 | Methylnoradrenaline,4TMS,isomer #1 | CC(N[Si](C)(C)C)C(O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1 | 1995.0 | Standard polar | 33892256 | Methylnoradrenaline,4TMS,isomer #2 | CC(C(O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2109.9 | Semi standard non polar | 33892256 | Methylnoradrenaline,4TMS,isomer #2 | CC(C(O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2115.0 | Standard non polar | 33892256 | Methylnoradrenaline,4TMS,isomer #2 | CC(C(O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2108.5 | Standard polar | 33892256 | Methylnoradrenaline,4TMS,isomer #3 | CC(C(O[Si](C)(C)C)C1=CC=C(O)C(O[Si](C)(C)C)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2113.5 | Semi standard non polar | 33892256 | Methylnoradrenaline,4TMS,isomer #3 | CC(C(O[Si](C)(C)C)C1=CC=C(O)C(O[Si](C)(C)C)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2135.0 | Standard non polar | 33892256 | Methylnoradrenaline,4TMS,isomer #3 | CC(C(O[Si](C)(C)C)C1=CC=C(O)C(O[Si](C)(C)C)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2123.3 | Standard polar | 33892256 | Methylnoradrenaline,4TMS,isomer #4 | CC(C(O)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2109.2 | Semi standard non polar | 33892256 | Methylnoradrenaline,4TMS,isomer #4 | CC(C(O)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2087.9 | Standard non polar | 33892256 | Methylnoradrenaline,4TMS,isomer #4 | CC(C(O)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2227.4 | Standard polar | 33892256 | Methylnoradrenaline,5TMS,isomer #1 | CC(C(O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2208.5 | Semi standard non polar | 33892256 | Methylnoradrenaline,5TMS,isomer #1 | CC(C(O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2100.7 | Standard non polar | 33892256 | Methylnoradrenaline,5TMS,isomer #1 | CC(C(O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1)N([Si](C)(C)C)[Si](C)(C)C | 2015.5 | Standard polar | 33892256 | Methylnoradrenaline,1TBDMS,isomer #1 | CC(N)C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O)C(O)=C1 | 2157.6 | Semi standard non polar | 33892256 | Methylnoradrenaline,1TBDMS,isomer #2 | CC(N)C(O)C1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1 | 2103.9 | Semi standard non polar | 33892256 | Methylnoradrenaline,1TBDMS,isomer #3 | CC(N)C(O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1 | 2124.1 | Semi standard non polar | 33892256 | Methylnoradrenaline,1TBDMS,isomer #4 | CC(N[Si](C)(C)C(C)(C)C)C(O)C1=CC=C(O)C(O)=C1 | 2276.6 | Semi standard non polar | 33892256 | Methylnoradrenaline,2TBDMS,isomer #1 | CC(N)C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1 | 2315.0 | Semi standard non polar | 33892256 | Methylnoradrenaline,2TBDMS,isomer #2 | CC(N)C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1 | 2299.7 | Semi standard non polar | 33892256 | Methylnoradrenaline,2TBDMS,isomer #3 | CC(N[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O)C(O)=C1 | 2464.3 | Semi standard non polar | 33892256 | Methylnoradrenaline,2TBDMS,isomer #4 | CC(N)C(O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1 | 2370.2 | Semi standard non polar | 33892256 | Methylnoradrenaline,2TBDMS,isomer #5 | CC(N[Si](C)(C)C(C)(C)C)C(O)C1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1 | 2443.9 | Semi standard non polar | 33892256 | Methylnoradrenaline,2TBDMS,isomer #6 | CC(N[Si](C)(C)C(C)(C)C)C(O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1 | 2463.2 | Semi standard non polar | 33892256 | Methylnoradrenaline,2TBDMS,isomer #7 | CC(C(O)C1=CC=C(O)C(O)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2574.6 | Semi standard non polar | 33892256 | Methylnoradrenaline,3TBDMS,isomer #1 | CC(N)C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1 | 2509.5 | Semi standard non polar | 33892256 | Methylnoradrenaline,3TBDMS,isomer #2 | CC(N[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1 | 2579.1 | Semi standard non polar | 33892256 | Methylnoradrenaline,3TBDMS,isomer #3 | CC(N[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1 | 2577.6 | Semi standard non polar | 33892256 | Methylnoradrenaline,3TBDMS,isomer #4 | CC(C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O)C(O)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2784.6 | Semi standard non polar | 33892256 | Methylnoradrenaline,3TBDMS,isomer #5 | CC(N[Si](C)(C)C(C)(C)C)C(O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1 | 2660.4 | Semi standard non polar | 33892256 | Methylnoradrenaline,3TBDMS,isomer #6 | CC(C(O)C1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2781.4 | Semi standard non polar | 33892256 | Methylnoradrenaline,3TBDMS,isomer #7 | CC(C(O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2813.5 | Semi standard non polar | 33892256 | Methylnoradrenaline,4TBDMS,isomer #1 | CC(N[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1 | 2797.3 | Semi standard non polar | 33892256 | Methylnoradrenaline,4TBDMS,isomer #1 | CC(N[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1 | 2711.1 | Standard non polar | 33892256 | Methylnoradrenaline,4TBDMS,isomer #1 | CC(N[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1 | 2482.8 | Standard polar | 33892256 | Methylnoradrenaline,4TBDMS,isomer #2 | CC(C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2982.7 | Semi standard non polar | 33892256 | Methylnoradrenaline,4TBDMS,isomer #2 | CC(C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2874.8 | Standard non polar | 33892256 | Methylnoradrenaline,4TBDMS,isomer #2 | CC(C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2504.9 | Standard polar | 33892256 | Methylnoradrenaline,4TBDMS,isomer #3 | CC(C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2973.6 | Semi standard non polar | 33892256 | Methylnoradrenaline,4TBDMS,isomer #3 | CC(C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2904.8 | Standard non polar | 33892256 | Methylnoradrenaline,4TBDMS,isomer #3 | CC(C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2518.8 | Standard polar | 33892256 | Methylnoradrenaline,4TBDMS,isomer #4 | CC(C(O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3035.2 | Semi standard non polar | 33892256 | Methylnoradrenaline,4TBDMS,isomer #4 | CC(C(O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2866.0 | Standard non polar | 33892256 | Methylnoradrenaline,4TBDMS,isomer #4 | CC(C(O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2605.7 | Standard polar | 33892256 | Methylnoradrenaline,5TBDMS,isomer #1 | CC(C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3216.7 | Semi standard non polar | 33892256 | Methylnoradrenaline,5TBDMS,isomer #1 | CC(C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2997.4 | Standard non polar | 33892256 | Methylnoradrenaline,5TBDMS,isomer #1 | CC(C(O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2536.9 | Standard polar | 33892256 |
|
---|